J&J | Built to matter: oncology startup strategies to stand out in a crowded market

J&J | Built to matter: oncology startup strategies to stand out in a crowded market

This Johnson & Johnson Innovation event brings together investors, pharma leaders, biotech executives and advisors to explore the strategic choices that can make oncology startups more investable, partnerable and attractive to potential acquirers.

Gain practical perspectives on the strategic decisions that can shape an oncology venture’s path forward. The programme will explore investor and buyer expectations, clinical development considerations and the factors that influence successful partnerships.

Register for the event here.

Testimonials

testimonial

I learned more in the training course for 3 days than I did in the last 3 months at my job. The lectures were informative & interesting.

Hanna Sonnig

Setterwalls Advokatbyrå, Sweden

testimonial

ASTP corroborates the strong need for profound insights and exchanges on practices, instruments and competencies that cut across functional, organisational, institutional, sectorial and geographic boundaries.

Koenraad Debackere

KU Leuven, Belgium

testimonial

It was great to experience the uncomplicated and fruitful exchange with colleagues from all over Europe, as well as the positive professional spirit of this conference.

Franck Döbrich

Universitat des Saarlandes WuT GmbH, Germany

testimonial

It is always encouraging to see that other TTOs are encountering the same problems that we do!

Aurore De Boom

Université Libré de Bruxelle, Belgium

testimonial

As always, superb topics and inspirational speakers. Great networking. Well worth the time out of the office!!! Great work HQ, thank you.

Peter Deakin

Chalmers University of Technology, Sweden